Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by MILNE GEORGE M JR, Director. Director active across 4 companies, notably CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Aggregated, 12 reports have been logged. Breakdown: 5 buys · 1 sell. Total volume traded: €2.3m. History available since 7 May 2021. The latest transaction was disclosed on 24 January 2025 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
George M. Milne Jr. is a Director at Charles River Laboratories International, Inc. and Amylyx Pharmaceuticals, Inc. In this role, he participates in the governance and strategic direction of these companies. George brings his expertise to help guide decisions that support the mission and objectives of Charles River and Amylyx.